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ABSTRACT
Whipple's disease is a rare multisystemic infectious disease that can mimic lymphoproliferative disorders and must be considered in 
the differential diagnosis of febrile syndromes. The authors describe the case of a 55-year-old man who presented to the Emergency 
Department with dyspnoea and abdominal pain. He had a 2-month history of fever, night sweats, asthenia and unintentional weight loss. 
Upon clinical examination he had bilateral inguinal lymphadenopathy. Blood tests showed iron-deficit anaemia and high C-reactive protein. 
Abdominal ultrasound showed mesenteric and iliac adenopathies and hepatosplenomegaly. The patient was admitted to the Internal 
Medicine department for additional testing. Flow cytometry analysis of peripheral blood showed CD5-positive monoclonal B-cell expansion. 
Excisional biopsy of a retroperitoneal adenopathy guided by computed tomography showed periodic acid–Schiff-positive bacilli inside the 
macrophages, further identified as Tropheryma whipplei through polymerase chain reaction. Bone marrow biopsy showed a scarce positive 
CD5 lymphoid population and haematopoietic alterations related to infection. The patient started treatment for T. whipplei with complete 
symptom resolution. This is the first case describing the simultaneous diagnosis of Whipple's disease and chronic lymphocytic leukaemia in 
a patient with constitutional symptoms, fever and lymphadenopathies.
LEARNING POINTS
• Whipple's disease can mimic lymphoproliferative disorders and should be considered in the differential diagnosis of lymphadenopathy 
and fever, even in the absence of gastrointestinal symptoms. 
• Most patients with chronic lymphocytic leukaemia are asymptomatic, but a minority have B symptoms and increased risk of infections.
• An accurate clinical history and differential diagnosis are fundamental; if the authors had not had a high level of suspicion, this patient 
could have been diagnosed with just chronic lymphocytic leukaemia and may have died if Whipple's disease had been left untreated. 
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CASE REPORT
A 55-year-old Caucasian man presented to the Emergency Department with dyspnoea and abdominal pain, without other gastrointestinal 
or respiratory symptoms. He also had a 2-month history of fever, night sweats, asthenia and unintentional weight loss (10% of basal weight). 
Upon physical examination he had bilateral inguinal lymphadenopathy, without other alterations. 
He had a previous medical history of obesity and obstructive sleep apnoea. He was taking no medication. He was an ex-smoker, with minimum 
alcohol intake and did not have any recent travel history. He lived in a rural area and worked as a house-builder. 
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Blood tests showed microcytic hypochromic anaemia with iron deficit (haemoglobin 10.7 g/dl, normal value 13–18 g/dl; mean corpuscular 
volume 75.1 fl, normal value 87–103 fl; mean corpuscular haemoglobin 25.7 pg, normal value 27–35 pg; 31.3% haematocrit, normal value 43–
55%; transferrin saturation of 9%, normal value 20–50%), high C-reactive protein (244 mg/l, normal value <3 mg/l) and high sedimentation 
rate (130 mm/h, normal value 0–15 mm/h), without leucocytosis, neutrophilia or lymphocytosis. Chest radiography and arterial blood gas 
testing were normal. Abdominal ultrasound showed widespread mesenteric and iliac adenomegalies and hepatosplenomegaly. The patient 
was admitted to the Internal Medicine department for additional testing. 
METHODS AND PROCEDURES
CT of the chest, abdomen and pelvis confirmed widespread retroperitoneal, mesenteric and iliac adenomegalies and hepatosplenomegaly 
(Fig. 1). 
Human immunodeficiency virus testing was negative. Blood cultures and the Mycobacterium tuberculosis direct test in respiratory samples 
were negative. An angiotensin-converting enzyme assay was normal. Immunological blood tests were normal, except for a slight elevation 
in immunoglobulin G4 (220 mg/dl, normal value 40–130 mg/dl). Gastroduodenal endoscopy was performed with duodenal biopsies, as was 
total colonoscopy; histology was normal. Fine-needle aspiration of an inguinal lymph node was inconclusive. Flow cytometry analysis of blood 
showed a positive CD5 monoclonal B-cell expansion. An excisional biopsy of a retroperitoneal adenopathy guided by CT was requested and 
showed periodic acid–Schiff (PAS)-positive bacilli inside the macrophages, identified as Tropheryma whipplei in polymerase chain reaction 
(PCR) (Fig. 2). Bone marrow biopsy showed a scarce positive CD5 lymphoid population and haematopoietic alterations reactive to infection.
Figure 1. Computed tomography of the abdomen and pelvis confirmed widespread 
retroperitoneal, mesenteric and iliac adenomegalies and hepatosplenomegaly. The arrow 
points to the largest conglomerate of lymphadenopathies
Figure 2. (A) Lymph node microbiopsy 
where numerous histiocytic cells 
are identified, in a ‘twisted towel’ 
arrangement, with abundant basophilic 
cytoplasm.(B) In the histochemical 
study with periodic acid–Schiff after 
diastasis, structures compatible with 
Tropheryma whipplei are observed 
in the histiocyte cytoplasm. Note the 
presence of a lipid vacuole typical of 
this entity 
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The patient started a 2-week antibiotic course of ceftriaxone, switched afterwards to an oral regimen of trimethoprim-sulfamethoxazole 
(160/800 mg). Within 2 months of a planned year-long treatment regimen, the patient had complete resolution of symptoms and had gained 
5 kg. 
DISCUSSION
Whipple's disease (WD) is a rare multisystemic infectious disease caused by the Gram-positive bacillus T. whipplei. WD can mimic 
lymphoproliferative disorders, malabsorption syndromes or rheumatic diseases[1,2]. The clinical spectrum of WD includes four types of 
manifestations: the classic form with chronic diarrhoea, abdominal pain, weight loss and arthralgias; the localized type, including endocarditis, 
uveitis, lymphadenitis and neurological manifestations; acute self-limited infections, such as acute gastroenteritis or pneumonia; and finally, 
the asymptomatic healthy carriers[3]. The prevalence of mesenteric lymphadenopathy in Whipple’s disease is reported to be 17% [2]. 
WD can be fatal if not correctly diagnosed and treated, and a high level of suspicion is required for diagnosis[1,2]. The incidence is unknown; 
patients are typically Caucasians males, with a mean age of 50 years and a history of agricultural exposure, as in our patient[1]. 
The gold standard diagnostic test used to be PAS staining of duodenal biopsy specimens, but this has poor specificity and sensitivity[3]. PCR 
has led to an expansion in diagnostic capacity, especially in localized WD with lymphadenitis, as reported in this case[1].
Patients diagnosed with WD should be treated with 2 weeks of parental antibiotics that can cross the blood–brain barrier, irrespective of 
suspected neurological involvement, followed by at least a year of oral antibiotics[1].
Chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL) are two manifestations of the same disease, a mature B-cell 
neoplasm characterized by progressive accumulation of monoclonal B-lymphocytes. The term CLL is used when the disease manifests 
primarily in the blood, whereas SLL is used when involvement is primarily lymph-nodal. Most patients are asymptomatic, but a minority 
have B symptoms and increased susceptibility to infections. Our patient became asymptomatic after starting WD-directed treatment. After 
5 years, he maintains only clinical vigilance since CLL does not require treatment unless symptoms or severe cytopenia develop [4].
In the literature, there is only one reported case of an association between these two entities, in which WD appears as a complication of CLL 
after 6 years of treatment with fludarabine[5].
REFERENCES
1.  Walters S, Valliani T, Przemioslo R, Rooney N. Whipple’s disease: an unexpected finding in a peripheral lymph node biopsy. Lancet 2014;383(9936):2268.
2.  Chizinga M, Schiliro D, Mullin B, La Barrie R. Mesenteric lymphadenitis as a presenting feature of Whipple’s disease. IDCases 2017;9:50–52. 
3.  Dolmans RAV, Boel CHE, Lacle MM, Kusters JG. Clinical manifestations,treatment, and diagnosis of Tropheryma whipplei infections. Clin Microbiol Rev 2017;30(2):529–555. 
4.  Nabhan C, Rosen ST. Chronic lymphocytic leukemia: a clinical review. JAMA 2014;312(21):2265–2276.
5.  Kuliszkiewicz-Janus M, Małecki R, Kuliczkowski K, Jeleń M. Whipple's disease as a complication of chronic lymphocytic leukemia treated with fludarabine. Pol Arch Med Wewn 
2002;108(3):887–891.
